Trump's administration faced scrutiny over investment claims, while his tariff plans were reported to threaten Roche investments, alongside commentary from Moody's chief economist Mark Zandi.
1 report, 0 independent
Updated Jul 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Trump's administration faced scrutiny over investment claims, while his tariff plans were reported to threaten Roche investments, alongside commentary from Moody's chief economist Mark Zandi.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Hoffmann-La Roche
Swiss healthcare company
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
-
Moody's Analytics
financial services business
Related events
Coverage
Newest first; wire copies grouped- Unknown outlet